Kautex Maschinenbau invests to enhance its pharmaceuticals and healthcare packaging division

German mechanical engineering company Kautex Maschinenbau has announced additional investments to its packaging, pharmaceuticals, and healthcare packaging businesses. Funds in tn the eight-figure region will be provided in Euros by the majority shareholder and measure will include the reallocation of human resources from the automotive division. Kautex Maschinenbau is one of the world’s leading manufacturers …

Huhtamaki launches recyclable pharma strip packaging

As an innovative producer of pharmaceutical and healthcare packaging, Huhtamaki has launched the first recyclable strip packaging for pharmaceutical solids – Push Tab loop. The pack provides cost-effective PVC-free tablet packaging with high barrier qualities. Designed to be a sustainable alternative to blister and cold-form packaging, this new addition to the Push Tab range was …

Syntegon supplies pharma packaging lines to Pharmax

Pharmax was set up to help the UAE become more independent from imported drugs and promote the local production of generic pharmaceuticals. With the UAE Government strongly supporting local manufacturers, Pharmax’s custom-built factory is equipped with the latest technology, meeting European, UAE and GMP standards. The facility received its GMP licence in 2018 and is …

Neopharma and GSK partnership produces first line of medicines packaged in UAE

Partners Neopharma and GSK have produced the first batch of medicines at local secondary packaging stage. 35,000 packages of the medicine were manufactured in three months, with plans to have them on UAE shelves within a month. The partnership, announced in April 2019, established Neopharma, a leading global pharmaceutical company based in the UAE, as …

Abu Dhabi Investment Authority acquires Nestlé́ Skin Health, rebranded as Galderma

Nestlé́ has announced the closing of the sale of Nestlé́ Skin Health to a consortium led by EQT and Luxinva, a wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) for a value of CHF 10.2 billion. This follows the completion of customary regulatory approvals and closing conditions. Galderma (“the Company”), rebranded from Nestlé́ …